首页> 外文期刊>Bone marrow transplantation >Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT
【24h】

Retroperitoneal fibrosis as manifestation of chronic GVHD after allogeneic hematopoietic SCT

机译:异体造血SCT后腹膜后纤维化为慢性GVHD的表现

获取原文
获取原文并翻译 | 示例
       

摘要

GVHD comprises a spectrum of diseases following hematopoietic SCT (HSCT), caused by the graft recognition of allogeneic Ag on host tissue cells with subsequent inflammation and structural tissue damage. The host target cells are mostly epithelial in nature, with only rare cases of manifestations in mesenchymal tissues. GVHD may, however, mimic any and even rare forms of autoimmune disease. Here we report two cases of retroperitoneal fibrosis (RPF) in allogeneic transplant recipients, in both cases associated with extensive chronic GVHD, suggesting that RPF may be considered as a manifestation of GVHD.The first patient was a 52-year-old man with anaplastic lymphoma kinase-negative anaplastic large T-cell lymphoma, who experienced relapse 14 months after dose-dense CHOEP primary chemotherapy. PBSCT from a matched unrelated donor was performed following conditioning treatment with fludarabine, CY and BU. The post-transplant course was complicated by severe chronic GVHD, with significant manifestations in more than two organs starting 8 months after transplantation. Symptoms included initial maculopapular rash of the whole integument, lichenoid lesions in the buccal mucosa and keratoconjunctivitis sicca of both eyes. Immunosuppressive treatment with systemic prednisolone and CsA with doses adjusted to maintain levels of 200ng/ml_ did not achieve an adequate therapeutic response.
机译:GVHD包括造血SCT(HSCT)之后的一系列疾病,这些疾病是由移植物识别宿主组织细胞上的同种异体Ag引起的,随后发生了炎症和结构性组织损伤。宿主靶细胞本质上大部分是上皮细胞,仅在间质组织中表现很少。但是,GVHD可以模仿任何形式甚至罕见的自身免疫性疾病。在这里,我们报道了异基因移植受者中的两例腹膜后纤维化(RPF),这两种情况均与广泛的慢性GVHD有关,这表明RPF可能被认为是GVHD的表现。第一例患者是一名52岁的间变性患者淋巴瘤激酶阴性的间变性大T细胞淋巴瘤,在剂量密集的CHOEP原发化疗后14个月复发。在用氟达拉滨,CY和BU调理处理后,从匹配的无关供体进行PBSCT。移植后的过程因严重的慢性GVHD而复杂化,在移植后8个月开始,在两个以上的器官中都有明显的表现。症状包括整个被膜的最初的黄斑丘疹,双眼颊粘膜的类苔藓样病变和干燥性角结膜炎。用全身性泼尼松龙和CsA进行免疫抑制治疗,并调整剂量以维持200ng / mL的水平无法获得足够的治疗效果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号